We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
2326
DELISTED
Athenex, Inc. Common Stock
ATNX
$121K ﹤0.01%
1,304
+968
+288% +$88K
LONA
2327
LeonaBio Inc
LONA
$73.9M
$120K ﹤0.01%
+1,175
New +$205K
CTMX icon
2328
CytomX Therapeutics
CTMX
$730M
$120K ﹤0.01%
18,924
+2,569
+16% +$20K
CCRN
2329
DELISTED
Cross Country Healthcare
CCRN
$119K ﹤0.01%
7,237
-3,412
-32% -$52.1K
MVBF icon
2330
MVB Financial
MVBF
$397M
$119K ﹤0.01%
2,785
+2,218
+391% +$90.5K
GOLD
2331
Gold.com Inc
GOLD
$1.27B
$118K ﹤0.01%
+5,094
New +$114K
TRNS icon
2332
Transcat
TRNS
$888M
$118K ﹤0.01%
2,088
SPRU icon
2333
Spruce Power Holding Corp
SPRU
$33.6M
$118K ﹤0.01%
+1,770
New +$104K
BSRR icon
2334
Sierra Bancorp
BSRR
$532M
$118K ﹤0.01%
4,635
FBRX icon
2335
Forte Biosciences
FBRX
$1.57B
$118K ﹤0.01%
+140
New +$126K
IMXI icon
2336
International Money Express
IMXI
$353M
$118K ﹤0.01%
7,924
+60
+0.8% +$899
EVC icon
2337
Entravision Communication
EVC
$820M
$118K ﹤0.01%
+17,593
New +$79.5K
RM icon
2338
Regional Management Corp
RM
$301M
$117K ﹤0.01%
+2,519
New +$109K
SSTI icon
2339
SoundThinking
SSTI
$107M
$117K ﹤0.01%
+2,402
New +$92.1K
PRVB
2340
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$116K ﹤0.01%
13,781
+1,525
+12% +$12.3K
HUN icon
2341
Huntsman Corp
HUN
$1.81B
$116K ﹤0.01%
4,360
+305
+8% +$8.67K
BTAI icon
2342
BioXcel Therapeutics
BTAI
$34.9M
$115K ﹤0.01%
248
+35
+16% +$19.1K
MAGN
2343
Magnera Corp
MAGN
$433M
$115K ﹤0.01%
634
-290
-31% -$57.1K
HTBK
2344
DELISTED
Heritage Commerce
HTBK
$115K ﹤0.01%
10,321
-5,836
-36% -$69.4K
ICAD
2345
DELISTED
iCAD Inc
ICAD
$115K ﹤0.01%
6,625
SPPI
2346
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$115K ﹤0.01%
30,577
-7,878
-20% -$27.4K
TNXP icon
2347
Tonix Pharmaceuticals
TNXP
$214M
0
BLBD icon
2348
Blue Bird Corp
BLBD
$2.05B
$115K ﹤0.01%
4,611
MBIN icon
2349
Merchants Bancorp
MBIN
$2.54B
$114K ﹤0.01%
4,361
ZVRA icon
2350
Zevra Therapeutics
ZVRA
$664M
$114K ﹤0.01%
+8,881
New +$95.4K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.